by The surgical drapes and gowns find wide application in modern healthcare facilities for infection control and maintaining sterility during surgical procedures. These products provide an effective barrier between the patient and microorganisms to prevent site infections. Surgical drapes are made from non-woven fabrics like polypropylene and used to cover patients and surgical instruments during operations. Gowns, on the other hand, are worn by surgeons and other medical staff involved in surgical procedures.
The Global Surgical Drapes and Gowns Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 74% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Global Surgical Drapes and Gowns Market Size are Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd. The growing prevalence of hospital-acquired infections and stringent regulation mandating the use of personal protective equipment in healthcare settings is driving the demand for surgical drapes and gowns. Moreover, favorable reimbursement policies and rising surgical procedures worldwide are fueling the growth of the global surgical drapes and gowns market.
Major players are expanding their production facilities in emerging regions to cater to the growing demand. For instance, in 2021 Allergan announced plans to expand its manufacturing plant in Costa Rica to double its production capacity for surgical gowns by 2024. The increasing preference for single-use surgical drapes and gowns among healthcare facilities due to concerns over infection control is a key trend in the market. Single-use products eliminate the need for sterilization and reduce the chance of contamination during reuse.
Market key trends
The increasing penetration of affordable surgical drape and gown products in developing regions is a major trend in the market. Major players are launching cost-effective generic variants tailored for budget-constrained healthcare facilities in Asia Pacific and Latin America. This helps increase the accessibility of essential protective equipment in these regions.
Porter’s Analysis
Threat of new entrants: The threat of new companies entering the surgical drapes and gowns market is moderate due to the presence of stringent regulatory requirements and established brands.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of alternative products and focus on price.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to the availability of alternative raw material suppliers and focus on quality.
Threat of new substitutes: The threat of new substitutes is low as there are limited product substitutes for surgical drapes and gowns.
Competitive rivalry: The competitive rivalry in the market is high due to regional and global presence of many established players.
Geographical Regions
North America accounts for the largest share of the global surgical drapes and gowns market, mainly due to increased number of surgeries and awareness about hospital-acquired infections.
The Asia Pacific region is expected to experience the fastest growth during the forecast period due to improving healthcare infrastructure, rising medical tourism, and increasing surgeries in India and China.
According to the United Nations Population Fund, four of the world’s ten most populous cities (which contribute significantly to the global disease burden) are located in India. The rapidly aging population, combined with the growing burden of non-communicable diseases and trauma injuries, is expected to increase the demand for various surgical procedures in India. This will drive the country’s surgical drapes and gowns market during the forecast period.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
